C3.ai insider: 28,628 stock options with attendance-based vesting
Rhea-AI Filing Summary
Director Jim H. Snabe received a stock option award for 28,628 shares of Class A common stock with an exercise price of $19.16. The option was granted on 10/03/2025 and has an expiration/exercise term tied to an expiration date of 10/02/2035. The award vests in 12.5% increments on the last day of each regularly scheduled quarterly board meeting starting on the vesting commencement date of 10/03/2025, subject to in-person attendance; any quarterly vesting missed will be suspended and may vest only after the second anniversary if attendance requirements are later met. The Form 4 was filed as a report by one reporting person and signed by an attorney-in-fact on 10/07/2025.
Positive
- Equity alignment: Grant of 28,628 options promotes long-term alignment between the director and shareholders
- Staggered vesting: 12.5% quarterly vesting encourages continued service and engagement through board meetings
Negative
- Attendance contingency: Vesting requires in-person attendance; missed quarters create Suspended Shares that delay vesting
- Deferred realization: Options expire in 2035, so economic benefit is long‑dated and depends on future stock performance
Insights
Grant ties director pay to long-term equity ownership with attendance-based vesting conditions.
The option award of $19.16 exercise price for 28,628 underlying shares vests in 12.5% quarterly tranches beginning 10/03/2025, which aligns the director's economic interest with shareholder outcomes over a multi-year period.
Vesting is explicitly conditional on in-person attendance at regularly scheduled board meetings; missed quarterly vesting is suspended and only becomes eligible after the second anniversary if attendance is subsequently satisfied, creating a governance control that enforces board participation. Monitor actual vesting events and any filings showing exercised or disposed shares over the next two years for changes in ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,628 | $0.00 | -- |
Footnotes (1)
- [object Object]